title: Exposure to cues associated with palatable food reward results in a dopamine D₂ receptor-dependent suppression of evoked synaptic responses in the entorhinal cortex.
abstract: BACKGROUND
  The lateral entorhinal cortex receives inputs from ventral tegmental area dopamine neurons that are activated by exposure to food-related cues, and exogenously applied dopamine is known to modulate excitatory synaptic responses within the entorhinal cortex.
  
  
  METHODS
  The present study used in vivo synaptic field potential recording techniques to determine how exposure to cues associated with food reward modulates synaptic responses in the entorhinal cortex of the awake rat. Chronically implanted electrodes were used to monitor synaptic potentials in the entorhinal cortex evoked by stimulation of the piriform (olfactory) cortex, and to determine how synaptic responses are modulated by food-related cues.
  
  
  RESULTS
  The amplitudes of evoked synaptic responses were reduced during exposure to cues associated with delivery of chocolate, and during delivery of chocolate for consumption at unpredictable intervals. Reductions in synaptic responses were not well predicted by changes in behavioural mobility, and were not fully blocked by systemic injection of either the D₁-like receptor antagonist SCH23390, or the muscarinic receptor antagonist scopolamine. However, the reduction in synaptic responses was blocked by injection of the D₂-like receptor antagonist eticlopride.
  
  
  CONCLUSIONS
  Exposure to cues associated with palatable food results in a suppression of synaptic responses in olfactory inputs to the entorhinal cortex that is mediated in part by activation of dopamine D₂ receptors.
authors.affiliation: Department of Psychology, Center for Studies in Behavioral Neurobiology, Concordia University, 7141 Sherbrooke Street W,, Rm, SP-244, Montréal H4B 1R6, Québec, Canada. andrew.chapman@concordia.ca.
authors.forename: Juliana A
authors.initials: JA
authors.lastname: Hutter
authors.forename: C Andrew
authors.initials: CA
authors.lastname: Chapman
mesh_terms: D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D003463:Cues; D018492:Dopamine Antagonists / Q000494:pharmacology; D065127:Dopamine D2 Receptor Antagonists; D018728:Entorhinal Cortex / Q000187:drug effects / Q000502:physiology*; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009833:Olfactory Pathways / Q000187:drug effects / Q000502:physiology; D051381:Rats; D020318:Rats, Long-Evans; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000502:physiology*; D012201:Reward; D012457:Salicylamides / Q000494:pharmacology; D012903:Smell
chemical_list: D001552:Benzazepines; D018492:Dopamine Antagonists; D065127:Dopamine D2 Receptor Antagonists; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; C534628:SCH 23390; D012457:Salicylamides; C045989:eticlopride